FindTrial
Sign In

Endothelial function after adjustable gastric banding, vasomotion and glucose tolerance

Endothelial function after adjustable gastric banding, vasomotion and glucose tolerance - Endothelial function after adjustable gastric banding

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36611
Enrollment
26
Registered
2011-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glucose tolerance Microvascular dysfunction

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. age 18-55 years 2. BMI > 35 3. Eligible for adjustable gastric banding

Exclusion criteria

Exclusion criteria: 1. cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, heart failure) 2. pulmonary disease 3. diabetes mellitus (FPG > 7.8 mmol/l) 4. renal failure 5. smoking 6. alcohol use > 4 U/day 7. use of medication (antihypertensive drugs, lipid lowering drugs, corticosteroids, NSAIDs, ciclosporin A, rifampicin) 8. pregnancy 9. insufficient knowledge of the Dutch language.

Design outcomes

Primary

MeasureTime frame
-Change in the vasomotion signal -Change in endothelial response to acetylcholine -Change in glucose-tolerance, as measured by OGTT—

Secondary

MeasureTime frame
none—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)